Tuesday, May 30, 2023
English News
  • Hyderabad
  • Telangana
  • Andhra Pradesh
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Reviews
    • Education Today
    • Property
    • Videos
    • Lifestyle
    • Rewind
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
  • Rewind
Home | World | Bharat Biotechs Partner Seeks Covaxin Approval In Us For Children Below 18 Years

Bharat Biotech’s partner seeks Covaxin approval in US for children below 18 years

"We are pleased to announce our EUA filing to the US-Food and Drug Administration (FDA) through our partners- Ocugen," tweeted Dr Raches Ella, Bharat Biotech's clinical lead for Covid-19 vaccines.

By ANI
Updated On - 11:20 AM, Sat - 6 November 21
Bharat Biotech’s partner seeks Covaxin approval in US for children below 18 years
whatsapp facebook twitter telegram

New Delhi: Bharat Biotech’s US partner Ocugen has announced that it had asked the US Food and Drug Administration (FDA) for Emergency Use Authorisation (EUA) of Covaxin for children below 18.

“We are pleased to announce our EUA filing to the US-Food and Drug Administration (FDA) through our partners- Ocugen,” tweeted Dr Raches Ella, Bharat Biotech’s clinical lead for Covid-19 vaccines.

The World Health Organisation (WHO) on Wednesday granted approval for Emergency Use Listing (EUL) for Bharat Biotech’s COVID-19 vaccine, Covaxin.

The approval was done on the recommendation of the Technical Advisory Group (TAG) for Emergency Use Listing (TAG-EUL), an independent advisory panel that provides recommendations to WHO on whether a COVID-19 vaccine can be listed for emergency use under the EUL procedure.

Bharat Biotech’s Covaxin and AstraZeneca and Serum Institute’s Covishield are the two widely used vaccines in India.

  • Follow Us :
  • Tags
  • Bharat Biotech’s Covaxin
  • Covaxin

Related News

  • Telangana government to provide booster dose from April 19

    Telangana government to provide booster dose from April 19

  • Telangana’s Genome Valley nurtures startups into MNCs

    Telangana’s Genome Valley nurtures startups into MNCs

  • Covishield immune responses against Covid variants higher than Covaxin: Study

    Covishield immune responses against Covid variants higher than Covaxin: Study

  • Bharat Biotech, MoHFW deny rush, political pressure in regulatory approval for Covaxin

    Bharat Biotech, MoHFW deny rush, political pressure in regulatory approval for Covaxin

  • CORBEVAX booster shot approved for 18 years and above jabbed with Covaxin, Covishield

    CORBEVAX booster shot approved for 18 years and above jabbed with Covaxin, Covishield

  • ‘Covaxin safe, well-tolerated in paediatrics’

    ‘Covaxin safe, well-tolerated in paediatrics’

Latest News

  • About 40 medical colleges lose recognition for non-compliance with NMC standards

    3 hours ago
  • Number of Rs 500 fake currency notes rose by 14.6 per cent: RBI

    3 hours ago
  • Opinion: AI and ethical dilemmas

    3 hours ago
  • Editorial: Mammoth task in Manipur

    4 hours ago
  • French Open: Seyboth Wild stuns Medvedev in five-set thriller

    4 hours ago
  • Tech Tok: Neuralink gets approval for human study

    4 hours ago
  • Number of frauds rose in FY23, amount involved halved: RBI data

    4 hours ago
  • New blood test to predict if cognitively healthy person will develop Alzheimer’s

    4 hours ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam